Loading organizations...
Loading organizations...
High-tech company specializing in gene sequencing and clinical diagnostics.
Cygnus Biosciences has raised $49.2M across 2 funding rounds.
Cygnus Biosciences has raised $49.2M in total across 2 funding rounds.
Cygnus Biosciences has raised $49.2M in total across 2 funding rounds.
Cygnus Biosciences's investors include China State-Owned Enterprises Structural Adjustment Fund, Wuxi Guolian, Lu Zhang, Long Yibin, Jingming BAO, Jinggong Hongyuan, Zhihua Yu, Star Ventures.
Cygnus Biosciences has raised $49.2M across 2 funding rounds. Most recently, it raised $29.6M Series C in August 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 9, 2022 | $29.6M Series C | China State-Owned Enterprises Structural Adjustment Fund | Wuxi Guolian |
| Nov 15, 2017 | $19.6M Other Equity | Lu Zhang, Long Yibin | Jingming BAO, Jinggong Hongyuan, Zhihua Yu, Star Ventures |